ChemCentre is one of the few testing laboratories in Australia to hold a Therapeutic Goods Administration Manufacturing Licence (MI-2019-LI-04564-1) and Good Manufacturing Practice (GMP) certification (MI-2020-LI-05509-1).
The licence and certification enable ChemCentre to offer analysis of final dose form medicinal cannabis products for legislative compliance based on Therapeutic Goods Order No. 93 (Standard for Medicinal Cannabis). This testing includes determination of an extensive cannabinoid profile as well as the analysis of terpenes, mycotoxins, heavy metals, pesticides, foreign matter and residual solvents, with a significant number of these analyses also being NATA accredited. ChemCentre is also able to undertake ICH Stability testing of products at several exposure conditions using climate chambers, to assist in the establishment of shelf life for various pharmaceutical products.
These capabilities can be accessed by manufacturers and distributors seeking to enter new and emerging local and international markets where this level of certification is required.
The accreditation also facilitates involvement in other analyses for the food, pharmaceutical and supplements industries and demonstrates to our clients our continued commitment to delivering a high-quality service.
Our highly trained scientific staff are also readily available to provide consultancy services that can assist with queries regarding product development, formulation and analysis.
Our scientists are experts at solving those difficult chemical problems, if you have questions regarding product analysis or development we are here to help.
Contact us now